"12-O-tetradecanoylphorbol-13-acetateSNNCI" . "C36H56O8"^^ . "C866"^^ . "LonomycinSYNCI" . . "Phorbol Myristate AcetateSYNCI" . "Tetradecanoylphorbol Acetate"^^ . . . "Hematologic cancer; bone marrow disorder"^^ . "Organic Chemical"^^ . "PHORBOL 12-MYRISTATE 13-ACETATE DIESTERPTFDANI40JAQ945" . "FDA"^^ . "16561-29-8"^^ . "12-O-tetradecanoylphorbol-13-acetatePTNCI-GLOSSCDR0000046763" . "Tetradecanoylphorbol Acetate"^^ . . "C0039654"^^ . "Tetradecanoylphorbol_Acetate"^^ . "A phorbol ester with potential antineoplastic effects. Tetradecanoylphorbol acetate (TPA) induces maturation and differentiation of hematopoietic cell lines, including leukemic cells. This agent may induce gene expression and protein kinase C (PKC) activity. In addition to potential antineoplastic effects, TPA may exhibit tumor promoting activity. (NCI04)NCI" . "43661"^^ . . "Tetradecanoylphorbol AcetatePTNCI" . "TPAPTNCI-GLOSSCDR0000044864" . "CHEBI:37537"^^ . "tetradecanoylphorbol acetatePTNCI-GLOSSCDR0000663334" . "PMAABNCI" . "TPA (Phorbol Ester)SYNCI" . "A substance being studied in the treatment of leukemias and lymphomas. It is also being studied in the treatment of other types of cancer. Tetradecanoylphorbol acetate affects many cell actions and may cause tumor cells to die. It is a type of phorbol ester.NCI-GLOSS" . "NI40JAQ945"^^ . "43661"^^ . "262244"^^ .